For Financial Professionals in the US
2022 INVESTMENT OUTLOOK
How should investors prepare for 2022?
Set the course with our Market GPS Investment Outlook
Corporate Debt Index
The Corporate Debt Index is a study into trends in company indebtedness around the world.
Quarterly insight from our equity teams to help clients navigate the markets and opportunities ahead.
Fixed Income Perspectives
Quarterly insight from our fixed income teams to help clients navigate the markets and opportunities ahead.
Sovereign Debt Index
The Sovereign Debt Index is a long-term study into trends in government indebtedness around the world, the investment opportunities this provides and the risks it presents.
Subscribe for relevant insights delivered straight to your inbox
An interview with Lauren Pearson and Emily Lassiter, financial advisors and co-creators of The Wealth Edit.
Why continued uncertainty reinforces the value of maintaining an allocation to high-quality bonds.
The near-term prospects for emerging market equities should be influenced by the trajectory of inflation and policy makers’ response to it.
Why we believe high-yield bond returns in 2022 will be driven more by understanding the mechanics of individual companies’ fundamentals.
Looking ahead to 2022 and considering the value of an allocation to truly diversified strategies after a year of record-breaking market highs.
The outlook for natural resources as decarbonization and the growing global emphasis on sustainability create powerful, multi-decade investment opportunities.
Our Head of Global Sustainable Equities explains why investors should not be wrong-footed amid increased volatility in 2022.
Jenna Barnard and John Pattullo believe developed market government bonds have a surprise in store in 2022.
Investors should be mindful of how the future path of inflation can impact the economy, policy and financial markets.
The Global Property Equities Team look back on 2021 and discuss the key trends impacting the global real estate sector.
Portfolio Manager Jeremiah Buckley sees continued progress in U.S. equities amid the economic recovery.
Fewer COVID-related disruptions and less regulatory uncertainty could give overlooked areas of health care a boost in 2022.